Clinical Trials

Phase Status Conditions

Showing 6 of 6 trials

More filters

Sponsor type Age bracket Sex Healthy volunteers Location

Trial ↑	Condition	Phase ↕	Status ↕	Criteria ↕	N ↕
VeriCel CardioCell therapy for refractory coronary artery disease Sponsored 4 sites · US	Coronary Artery Disease	P3	Recruiting	Adults 45–80 View criteria →	240
Adagrasib + pembrolizumab in KRAS G12C-mutated non-small cell lung cancer 4 sites · US + UK	Lung Cancer	P2	Active, not recruiting	Adults ≥ 18 View criteria →	140
Bridge-enhanced ACL repair versus reconstruction (BEAR-III) 1 site · US	Knee Ligament Injury (ACL Tear)	P4	Recruiting	Adults 13–35 View criteria →	200
Donanemab in early symptomatic Alzheimer's disease (TRAILBLAZER-ALZ 2) 6 sites · US + Sweden + others	Alzheimer's Disease	P3	Completed	Adults 60–85 View criteria →	1,500
Donanemab long-term cognitive outcomes study 6 sites · US	Alzheimer's Disease	P3	Recruiting	Adults 60–85 View criteria →	1,200
Local antibiotic delivery for severe periodontitis 4 sites · US	Dental Caries (Tooth Decay)	P2	Recruiting	Adults ≥ 30 View criteria →	120

Show per page

Showing 1–6 of 6 trials